The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

NCT04632862 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG: DWP16001

Sponsor

Daewoong Pharmaceutical Co. LTD.